Jeff Johnson
Stock Analyst at Robert W. Baird
(4.59)
# 969
Out of 5,118 analysts
625
Total ratings
50.5%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Reiterated: Hold | $15 → $9 | $9.46 | -4.86% | 55 | Nov 6, 2026 | |
| NVST Envista Holdings | Reiterated: Hold | $26 → $29 | $25.17 | +15.22% | 40 | Nov 5, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $104 → $114 | $105.59 | +7.96% | 39 | Nov 5, 2026 | |
| PODD Insulet | Reiterated: Buy | $175 → $200 | $146.51 | +36.51% | 47 | Nov 4, 2026 | |
| SYK Stryker | Reiterated: Buy | $385 → $334 | $325.87 | +2.49% | 38 | Oct 30, 2026 | |
| ALGN Align Technology | Downgraded: Hold | $218 → $162 | $166.00 | -2.41% | 67 | Oct 15, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $109 | $86.05 | +26.67% | 58 | Oct 9, 2026 | |
| BBNX Beta Bionics | Reiterated: Hold | $14 → $16 | $15.70 | +1.91% | 8 | Sep 15, 2026 | |
| COO The Cooper Companies | Downgraded: Hold | $85 → $61 | $62.36 | -2.18% | 56 | Sep 10, 2026 | |
| DXCM DexCom | Reiterated: Buy | $80 → $105 | $79.41 | +32.23% | 61 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $17 | $13.33 | +27.53% | 39 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $37 | $27.16 | +36.23% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 77.87 → CHF 73.78 | CHF 61.30 | +20.35% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $16.91 | +77.41% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.75 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $2.76 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $100.61 | n/a | 1 | Apr 11, 2016 |
DENTSPLY SIRONA
Nov 6, 2026
Reiterated: Hold
Price Target: $15 → $9
Current: $9.46
Upside: -4.86%
Envista Holdings
Nov 5, 2026
Reiterated: Hold
Price Target: $26 → $29
Current: $25.17
Upside: +15.22%
Zimmer Biomet Holdings
Nov 5, 2026
Reiterated: Hold
Price Target: $104 → $114
Current: $105.59
Upside: +7.96%
Insulet
Nov 4, 2026
Reiterated: Buy
Price Target: $175 → $200
Current: $146.51
Upside: +36.51%
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: $385 → $334
Current: $325.87
Upside: +2.49%
Align Technology
Oct 15, 2026
Downgraded: Hold
Price Target: $218 → $162
Current: $166.00
Upside: -2.41%
Henry Schein
Oct 9, 2026
Reiterated: Buy
Price Target: $109
Current: $86.05
Upside: +26.67%
Beta Bionics
Sep 15, 2026
Reiterated: Hold
Price Target: $14 → $16
Current: $15.70
Upside: +1.91%
The Cooper Companies
Sep 10, 2026
Downgraded: Hold
Price Target: $85 → $61
Current: $62.36
Upside: -2.18%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $105
Current: $79.41
Upside: +32.23%
Jul 14, 2026
Reiterated: Hold
Price Target: $14 → $17
Current: $13.33
Upside: +27.53%
May 8, 2026
Reiterated: Buy
Price Target: $45 → $37
Current: $27.16
Upside: +36.23%
May 7, 2026
Reiterated: Buy
Price Target: CHF 77.87 → CHF 73.78
Current: CHF 61.30
Upside: +20.35%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $16.91
Upside: +77.41%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $42.75
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $67
Current: $2.76
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $100.61
Upside: n/a